The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.

Bauersachs J, Solomon SD, Anker SD, Antorrena-Miranda I, de Boer RA, Filippatos G, Friede T, Hauke W, Ponikowski P, Vardeny O, Altschul R, Gamborg M, Vinther K, Thum T

Open source

DOI: 10.1038/s41591-026-04408-4
Published: 2026 Jul
Container: Nature medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04408-4,
  title = {The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.},
  author = {Bauersachs J and Solomon SD and Anker SD and Antorrena-Miranda I and de Boer RA and Filippatos G and Friede T and Hauke W and Ponikowski P and Vardeny O and Altschul R and Gamborg M and Vinther K and Thum T},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04408-4},
  url = {https://doi.org/10.1038/s41591-026-04408-4}
}

RIS

TY  - JOUR
TI  - The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.
AU  - Bauersachs J
AU  - Solomon SD
AU  - Anker SD
AU  - Antorrena-Miranda I
AU  - de Boer RA
AU  - Filippatos G
AU  - Friede T
AU  - Hauke W
AU  - Ponikowski P
AU  - Vardeny O
AU  - Altschul R
AU  - Gamborg M
AU  - Vinther K
AU  - Thum T
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04408-4
UR  - https://doi.org/10.1038/s41591-026-04408-4
ER  -

APA

J, B., SD, S., SD, A., I, A., RA, D. B., G, F., T, F., W, H., P, P., O, V., R, A., M, G., K, V., & T, T. (2026). The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04408-4

Source records

pubmed · retrieved 2026-11-10T14:33:38.917Z